Back icon Back
Colossal

Colossal

Company

Colossal Secures $200M in Series C Funding From TWG Global on the Back of Numerous World’s First Scientific Breakthroughs on Path to De-Extinction
Funding allows for expansion of labs, teams, and additional species candidates for de-extinction
DALLAS–(BUSINESS WIRE)–Colossal Biosciences, the world’s first de-extinction company, has today announced $200M in

https://www.businesswire.com/news/home/20250115365884/en/Colossal-Secures-%24200M-in-Series-C-Funding-From-TWG-Global-on-the-Back-of-Numerous-Worlds-First-Scientific-Breakthroughs-on-Path-to-De-Extinction

Date

Jan 15, 2025

Category

biotech

Lead investor

Country Icon TWG Global

Stage

Series C

Size

$200M

Explore similar Investments to Colossal

Company
Size
Date
Lead Investor
Press
Orchids

Orchids

Company
$2M
Jul 16, 2025
Investor Y Combinator
Source
Cyera

Cyera

Company
$300M
Nov 20, 2024
Investor Accel
Source
Tavily

Tavily

Company
$20M
Aug 6, 2025
Investor Insight Partners
Source
Ashby

Ashby

Company
$30M
Jun 3, 2024
Investor Lachy Groom
Source
Sola

Sola

Company
$30M
Mar 11, 2025
Investor S32
Source
Ivo

Ivo

Company
$16M
Feb 5, 2025
Investor Costanoa Ventures
Source
Nooks

Nooks

Company
$43M
Oct 24, 2024
Investor Kleiner Perkins
Source
Clay

Clay

Company
$62M
Jun 27, 2024
Investor Meritech Capital
Source
Baseten

Baseten

Company
$40M
Mar 4, 2024
Investor Spark Capital
Source
Flare

Flare

Company
$30M
Dec 11, 2024
Investor Base10 Partners
Source
Pipedream

Pipedream

Company
$13M
Apr 23, 2024
Investor Starship Ventures
Source
StackOne

StackOne

Company
$20M
May 6, 2025
Investor GV
Source

Startups, venture funds
& everything in between.

Explore verified companies, top VCs, and practical guides built to help you raise, invest, and grow faster.
Made by Omnius. For builders, by builders.
Venture Funds Startups Investments Events Programs Case Studies Interviews & Lectures Reports & Publications